Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan

Journal of Biomedical Science

Volumn 12, Issue 6, 2005, Pages 925-936

  Lin, Hsiang Ju ^a   Cherng, Jaw Ming ^b   Hung, Man Shan ^c   Sayion, Yiyang ^c   Lin, Jung Chung ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

A2 restricted epitopes; Cytotoxic T lymphocytes; EBV; LMP 1 oncoprotein; Nasopharyngeal carcinoma

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; LATENT MEMBRANE PROTEIN 1; VIRUS PROTEIN;

ARTICLE; CHINA; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; HUMAN; MOLECULAR RECOGNITION; MUTATION; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TAIWAN;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHINA; CYTOKINES; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MUTATION; NASOPHARYNGEAL NEOPLASMS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TAIWAN; TEMPERATURE; TIME FACTORS; VARIATION (GENETICS); VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 30544435475     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9017-y     Document Type: Article

References (29)

1. de The G. Epidemiology of Epstein-Barr virus and associated diseases. In: Roizman (Ed), The Herpesvirus, Plenum Press, New York, 1982, Vol. 1. pp. 25-87.
2. Ho J.H.C., Epidemiology of nasopharyngeal carcinoma (NPC), In: Ablashi D.V., Huang A.T., Pagano J.S., Pearson G.R. and Yang C.S. (Eds.), Epstein-Barr Virus and Human Disease. Humana Press, New Jersey, 1990, pp. xli-xliv.
3. Raab-Traub N., Epstein-Barr virus and nasopharyngeal carcinoma. Cancer Biol. 3: 297-307, 1992.
4. Rickinson A.B. and Kieff E. Epstein-Barr virus. In: Field B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B. and Straus S.E. (Eds.), Field Virology, Lippincott Raven Publishers, Philadelphia, 1996, Vol. 2. pp. 2397-2446.
5. Khanna R., Burrows N.J. and Poulsen L.M., Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1- specific cytotoxic T lymphocytes. Eur. J. Immunol. 28: 451-458, 1998.
6. Lee S.P., Thomas W.A., Murray R.J., Khanim F., Kaur S., Young L.S., Rowe M., Kurilla M. and Rickinson A.B., HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67: 7428-7435, 1993.
7. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald Mullen P.M., Klein G., Kurilla M.G. and Masucci M.G., Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688, 1995.
8. Khanna R., Burrows S.R., Steigerwald-Mullen P.M., Moss D.J., Kurilla M.G. and Cooper L., Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing. Int. Immunol. 9: 1537-1543, 1997.
9. Lin J.-C., Cherng J.-M., Lin H.-J., Tsang C.-W., Liu Y.-X. and Lee S.P., Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted "epitope-loss variant". J. Gen. Virol. 85: 2023-2034, 2004.
10. Altman J.D., Moss P.A.H., Goulder P.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J. and Davis M.M., Phenotypic analysis of antigen specific T lymphocytes. Science 274: 94-96, 1996.
11. Moss D.J., Misko I.S., Burrows S.R., Burman K., McCarthy R. and Sculley T.B., Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 331: 719-721, 1988.
12. Murray R.J., Kurilla M.G., Brooks J.M., Thomas W.A., Rowe M., Kieff E. and Rickinson A.B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 176: 157-168, 1992.
13. Burrows J.M., Burrows S.R., Poulsen L.M., Sculley T.B., Moss D.J. and Khanna R., Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J. Virol. 70: 2490-2496, 1996.
14. Salter R.D. and Cresswell P., Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5: 943-949, 1986.
15. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V.S. and McMichael A.J., Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186: 859-865, 1997.
16. Hislop A.D., Gudgeon N.H., Callan M.F.C., Fazou C., Hascgawa H., Salmon M. and Rickinson A.B., EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167: 2019-2029, 2001.
17. Tan L.C., Gudgeon N., Annels N.E., Hansasuta P., O'Callaghan C. A., Rowland-Jones S., McMichael A.J., Rickinson A.B. and Callan M.F.C., A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162: 1827-1835, 1999.
18. Steven N.M., Annels N.E., Kumar A., Leese A.M., Kurilla M.G. and Rickinson A.B., Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185: 1605-1617, 1997.
19. Duraiswamy J., Burrow J.M., Bharadwaj M., Burrow S.R., Cooper L., Pimtanothai N. and Khanna R., Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J. Virol. 77: 7401-7410, 2003.
20. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Speigel H.M., Conlon C., Spina C.A. et al. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75, 2000.
21. Valitutti S., Muller S., Dessing M. and Lanzavecchia A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183: 1917-1921, 1996.
22. Chapman A.L.N., Rickinson A.B., Thomas W.A., Jarrett R.F., Crocker J. and Lee S.P., Epstein-Barr virus-specific cytotoxic T lymphocytes responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res. 61: 6219-6226, 2001.
23. Rickinson A.B. and Moss D.J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15: 405-431, 1997.
24. Khanna R., Busson P., Burrows S.R., Raffoux C., Moss D.J., Nicholls J.M. and Cooper L., Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res. 58: 310-314, 1998.
25. Khanna R., Burrows S.R., Kurilla M.G., Jacob C.A., Misko I.S., Sculley T.B., Kieff E. and Moss D.J., Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176: 169-176, 1992.
26. Riddell S.R., Watanabe K.S., Goodrick J.M., Li C.R., Agha M.E. and Greenberg P.D., Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241, 1992.
27. De Campos-Lima P.-O., Gavioli R., Zhang Q.-J., Wallace L., Rowe M., Rickinson A.B. and Masucci M., HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260: 98-100, 1993.
28. De Campos-Lima P.-O., Levitsky V., Brooks J., Lee S.P., Hu L.F., Rickinson A.B. and Masucci M., T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179: 1297-1305, 1994.
29. Khanna R., Geographic (not immunological) constraints define long-term evolutionary dynamics of Epstein-Barr virus. Epstein-Barr Virus Rep. 5(6) 127-131, 1998.